Brown Rudnick, LLP, on Behalf of Prime Therapeutics

Law Firm

Based in DC

🤖

AI Overview

With $40K in lobbying spend across 6 quarterly filings, Brown Rudnick, LLP, on Behalf of Prime Therapeutics is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2019.

$40K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$40K
2019	$0

Issues Lobbied

Health Issues Medicare/Medicaid Pharmacy

Lobbying Firms

Hooper, Lundy & Bookman, P.C.

Lobbyists

Martin Corry Lisa Layman

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy

•Issues relating to the regulation of PBMs and healthcare.

•H.R.2212 and S.974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (or the CREATES Act of 2017); H.R. 1316 - The Prescription Drug Price Transparency Act; S.771 and H.R.1776 -

•H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 3528 & S. 2460-Every Prescription Conveyed Securely